BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1851021)

  • 1. Pilot study of teniposide in combination chemotherapy for small cell lung cancer.
    Giaccone G; Schmidt G; Calciati A
    Eur J Cancer; 1991; 27(2):141-3. PubMed ID: 1851021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teniposide alone and in combination chemotherapy in small cell lung cancer.
    Giaccone G
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):75-80. PubMed ID: 1329229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Alberto P; Hürny C; Bacchi M; Leyvraz S; Thürlimann B; Cerny T; Martinelli G; Stahel R; Ludwig C
    Ann Oncol; 1995 Jan; 6(1):41-8. PubMed ID: 7536028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
    Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
    Goss GD; Vincent M; Corringham R; Germond C; Sinoff C; Kane G; Rowen J; Corringham S; Dhaliwal H
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):69-74. PubMed ID: 1329228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with teniposide (VM26) and carboplatin in small cell lung cancer.
    Goss GD; Vincent M; Germond C; Corringham S; Rowen J; Dhaliwal H; Corringham R
    Am J Clin Oncol; 1993 Aug; 16(4):295-300. PubMed ID: 8392286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesine.
    Niiranen A; Holsti LR; Salmo M; Holsti P; Mattson K
    Am J Clin Oncol; 1987 Dec; 10(6):507-11. PubMed ID: 2825508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
    Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
    Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teniposide for meningeal carcinomatosis of small cell lung cancer.
    van der Graaf WT; Haaxma-Reiche H; Burghouts JT; Postmus PE
    Lung Cancer; 1993 Dec; 10(3-4):247-9. PubMed ID: 8075970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short duration combination chemotherapy in the treatment of small cell lung cancer.
    Dorward AJ; Banham SW; Hutcheon AW; Ahmedzai S; Cunningham D; Gregor A; Soukop M; Stack BH; Mackay NS; Kaye SB
    Thorax; 1986 Sep; 41(9):688-91. PubMed ID: 3024351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.